Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacia and Upjohn Expands Deal with Incyte

Premium

PALO ALTO, Calif.-- Incyte Pharmaceuticals expanded its genomic database deal with Pharmacia and Upjohn this month, giving Pharmacia license to use Incyte's PathoSeq database of microbial genomic information. Since its relationship with Incyte was formed in 1994, Pharmacia has obtained access to a series of Incyte LifeSeq databases containing human gene sequence and expression data, full-length genes, and gene mapping information, as well as Incyte's ZooSeq animal database. The companies said Pharmacia would use the PathoSeq data in its infectious disease programs. Roy Whitfield, Incyte's CEO, said the addition of PathoSeq to Pharmacia's research and development process will allow drug developers to cross-reference human, animal, and microbial data "to uncover relationships between species and develop better-targeted therapies."

PathoSeq contains genomic data for more than 40 bacterial and fungal microorganisms. Incyte will receive annual access fees and could receive royalties on sales of products developed by Pharmacia with Incyte technology and data.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.